Among the many forms of cancer we know, ovarian cancer is the latest and the least understood. A new type of drug will be the first drug available for ovarian cancer. The drug is manufactured by Astrazeneca and it has been granted formal approval from the European Commission. The approval was widely expected after the […]
Tamoxifen offers Protection Against Breast Cancer: IBIS-I Trials
A new study conducted by International Breast Cancer Intervention society termed IBIS-I have suggested that Tomoxifen can prove to be an effective drug against the breast cancer. The study suggested that Tamoxifen intake five years among women can decrease the risk of breast cancer among high risk patients. The researchers said the breast cancer risk […]
FDA’s Advisory Panel Approves Actavis (ACT) Anti-Biotic
The US Food & Drug Administration’s (FDA) Anti-Infective Drugs Advisory Committee has prescribed trail anti-biotic, ceftazidime-avibactam from Actavis plc for treating intricate intra-abdominal diseases (cIAI) and convoluted urinary tract diseases (cUTI) brought on by drug resistant bacteria. The medication has been co developed by Actavis and Astrazeneca plc under an agreement which gives Actavis the […]